Your browser doesn't support javascript.
loading
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model.
Suominen, Mari I; Knuuttila, Matias; Schatz, Christoph A; Schlicker, Andreas; Vääräniemi, Jukka; Sjöholm, Birgitta; Alhoniemi, Esa; Haendler, Bernard; Mumberg, Dominik; Käkönen, Sanna-Maria; Scholz, Arne.
Afiliação
  • Suominen MI; Pharmatest Services Ltd., 20520 Turku, Finland.
  • Knuuttila M; Aurexel Life Sciences Ltd., 21240 Askainen, Finland.
  • Schatz CA; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany.
  • Schlicker A; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany.
  • Vääräniemi J; Pharmatest Services Ltd., 20520 Turku, Finland.
  • Sjöholm B; Aurexel Life Sciences Ltd., 21240 Askainen, Finland.
  • Alhoniemi E; Inoi Oy, 20100 Turku, Finland.
  • Haendler B; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany.
  • Mumberg D; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany.
  • Käkönen SM; Aurexel Life Sciences Ltd., 21240 Askainen, Finland.
  • Scholz A; Institute of Biomedicine, University of Turku, 20520 Turku, Finland.
Int J Mol Sci ; 24(3)2023 Jan 22.
Article em En | MEDLINE | ID: mdl-36768509

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Rádio (Elemento) / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Rádio (Elemento) / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article